Fate Therapeutics FATE Balance Sheet (2012-2026)

NASDAQ FATE
$2.48 +0.06 (+2.48%)
As of: Sep 4, 2026 · 3:59 PM EDT
Reported Financials

Fate Therapeutics Quarterly Balance Sheet

Periods 56 quarters
Latest Jun 2026

Fate Therapeutics reported total assets of $260.10M and total liabilities of $106.67M for the quarter ended Jun 2026, down 30.0% year over year. This balance sheet covers 56 quarters of results from Sep 2012 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Accumulated Depreciation
16.95M30.38M47.63M35.14M36.22M
Receivables - AccuredAcc. Int. Receivables
1.70M1.10M1.40M0.00M1.00M0.80M0.90M0.00M1.00M0.90M0.90M1.70M1.90M2.10M2.00M2.00M1.40M0.70M0.80M0.30M
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
129.18M133.58M64.74M55.27M82.09M61.33M42.02M46.80M33.33M41.87M121.32M36.92M37.91M36.06M44.92M41.25M40.62M46.63M174.80M153.80M
Receivables - NetNet Receivables
7.31M8.68M13.85M13.13M10.22M38.48M13.50M2.83M1.54M1.83M0.86M1.05M4.13M3.54M2.41M1.40M0.68M0.92M0.70M0.70M
Receivables
7.31M8.68M13.85M13.13M10.22M38.48M13.50M2.83M1.54M1.83M0.86M1.05M4.13M3.54M2.41M1.40M0.68M0.92M0.70M0.70M
Prepaid Assets
7.70M8.83M11.45M17.18M19.97M27.37M15.49M11.41M12.90M14.54M9.97M13.46M9.24M9.30M5.39M6.17M5.15M4.13M4.00M3.48M
Current Assets
693.71M633.41M599.08M599.16M535.33M502.07M437.89M392.18M364.17M331.54M394.38M319.39M310.29M291.91M248.22M230.40M221.25M208.70M179.53M157.95M
Non-Current Assets
Property, Plant & Equipment (Net)
74.62M91.53M97.86M103.12M109.12M110.02M108.59M106.33M101.71M96.84M92.12M87.53M82.39M64.38M62.76M61.10M59.48M56.92M54.26M51.55M
Long-Term Investments
124.88M100.66M67.94M11.93M13.94M4.94M3.91M7.29M0.98M7.59M47.16M33.61M27.66M32.29M26.10M10.30M1.47M
Long-Term Deferred Tax
374.09M399.33M
Other Non-Current Assets
15.23M15.23M15.23M15.23M15.23M15.23M15.23M15.18M15.18M15.18M15.18M15.18M10.23M10.23M10.23M10.23M10.23M10.23M10.05M10.05M
Non-Current Assets
290.86M288.04M259.31M207.90M214.02M203.49M192.45M192.57M179.61M174.68M175.52M209.43M184.68M148.78M150.45M141.24M122.42M110.23M105.39M102.15M
Assets
984.57M921.46M858.39M807.06M749.35M705.56M630.34M584.76M543.79M506.22M569.89M528.82M494.97M440.69M398.67M371.63M343.67M318.94M284.92M260.10M
Liabilities
Current Liabilities
Accounts Payables
6.44M8.61M11.44M8.42M9.59M8.27M9.86M7.51M5.71M4.72M6.76M5.50M6.35M9.37M4.19M4.04M3.50M2.66M3.28M3.26M
Notes Payables
Payables
6.44M8.61M11.44M8.42M9.59M8.27M9.86M7.51M5.71M4.72M6.76M5.50M6.35M9.37M4.19M4.04M3.50M2.66M3.28M3.26M
Accumulated Expenses
54.00M42.41M35.11M40.52M50.15M53.93M31.51M29.47M28.54M27.51M32.04M22.65M23.58M21.35M17.21M18.18M17.57M20.02M13.64M14.90M
Other Accumulated Expenses
10.80M11.71M13.03M12.29M18.90M19.18M10.23M8.11M8.63M8.12M18.65M8.01M10.50M6.36M6.77M4.87M3.86M4.41M3.96M3.28M
Short term Debt
Current Leases
4.70M5.58M5.58M5.72M5.75M5.63M5.54M5.79M5.98M6.18M6.40M6.64M6.89M7.42M6.54M5.66M4.75M4.56M4.74M4.92M
Current Deferred Revenue
23.55M21.48M22.57M33.66M35.24M42.23M1.74M1.93M1.11M0.69M0.16M0.60M0.39M0.21M0.01M0.38M0.58M
Total Current Liabilities
91.88M81.28M77.91M91.52M103.94M114.05M48.65M44.69M41.33M39.09M45.37M34.79M37.42M38.52M28.16M28.67M28.11M36.07M30.69M32.59M
Non-Current Liabilities
Non-Current Debt
Convertible Debt
Non-Current Deffered Revenue
32.56M27.12M22.53M17.74M12.41M
Pension
12.90M12.90M12.90M
Preferred Stock Liabilities
Operating Leases
104.36M109.24M107.94M106.59M105.16M103.71M102.07M100.56M98.98M97.36M95.67M93.92M92.08M77.85M76.78M75.67M74.49M73.29M72.05M70.75M
Other Non-Current Liabilities
24.63M24.17M15.81M9.93M9.04M3.86M2.14M1.75M0.70M1.35M2.74M1.18M1.20M0.53M0.25M0.32M0.41M0.28M0.36M0.94M
Total Non-Current Liabilities
229.61M218.45M209.18M216.65M222.31M217.76M150.72M145.25M140.31M136.45M141.04M130.65M131.45M121.44M110.01M109.95M109.19M111.47M104.85M105.72M
Total Liabilities
254.24M242.62M224.99M226.58M231.35M221.62M152.86M147.00M141.01M137.80M143.78M131.84M132.64M121.97M110.26M110.27M109.61M111.75M105.21M106.67M
Shareholder's Equity
Total Debt
Common Equity
730.33M678.84M633.39M580.48M518.00M483.94M477.47M437.75M402.78M368.42M426.12M396.98M362.33M318.73M288.41M261.36M234.07M207.18M179.71M153.44M
Liabilities and Shareholders Equity
984.57M921.46M858.39M807.06M749.35M705.56M630.34M584.76M543.79M506.22M569.89M528.82M494.97M440.69M398.67M371.63M343.67M318.94M284.92M260.10M
Retained Earnings
1,430.77M1,448.58M1,470.92M1,494.64M1,515.60M1,536.50M1,547.70M1,560.68M1,570.78M1,580.03M1,685.93M1,695.45M1,707.21M1,716.34M1,723.71M1,730.87M1,735.73M1,741.26M1,745.19M1,749.12M
Preferred Shares
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Treasury Shares